Compound 458
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](COCc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1
- InChi:
InChI=1S/C45H51ClF3N7O5S2/c1-54(2)22-18-36(30-61-29-32-8-4-3-5-9-32)52-41-17-16-38(26-43(41)62(57,58)45(47,48)49)63(59,60)53-44-40-21-25-56(28-42(40)50-31-51-44)37-19-23-55(24-20-37)27-34-10-6-7-11-39(34)33-12-14-35(46)15-13-33/h3-17,26,31,36-37,52H,18-25,27-30H2,1-2H3,(H,50,51,53)/t36-/m1/s1
- InChiKey:
TXVKIODSSHFXBS-PSXMRANNSA-N
External links
88540211 |
External search
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 25 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.85 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 925.30 g/mol | |||
HBA | 12 | |||
HBD | 2 | |||
HBA + HBD | 14 | |||
AlogP | 6.21 | |||
TPSA | 137.07 | |||
RB | 17 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 25 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 6.85 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4462 | Navitoclax | DB12340 | |
0.4460 | GDC-0349 | DB13072 | |
0.3943 | Rivipansel | DB12778 | |
0.3878 | Sulfaisodimidine | DB13283 | |
0.3813 | Omidenepag isopropyl | DB15071 | |
0.3802 | Presatovir | DB12165 | |
0.3739 | Sparsentan | DB12548 | |
0.3728 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.3699 | Talotrexin | DB06178 | |
0.3686 | (1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate | DB08498 | |
0.3676 | (4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE | DB07583 | |
0.3666 | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE | DB07689 | |
0.3666 | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE | DB07765 | |
0.3618 | CH-5132799 | DB13051 | |
0.3617 | 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine | DB07585 |